ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 33 filers reported holding ACER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,502 | +13.8% | 10,290 | -6.5% | 0.00% | – |
| Q1 2023 | $8,350 | -69.8% | 11,009 | 0.0% | 0.00% | – |
| Q4 2022 | $27,633 | +84.2% | 11,009 | -0.6% | 0.00% | – |
| Q3 2022 | $15,000 | +7.1% | 11,075 | 0.0% | 0.00% | – |
| Q2 2022 | $14,000 | -56.2% | 11,075 | -0.5% | 0.00% | – |
| Q1 2022 | $32,000 | +28.0% | 11,133 | 0.0% | 0.00% | – |
| Q4 2021 | $25,000 | -13.8% | 11,133 | 0.0% | 0.00% | – |
| Q3 2021 | $29,000 | -9.4% | 11,133 | 0.0% | 0.00% | – |
| Q2 2021 | $32,000 | -20.0% | 11,133 | -12.4% | 0.00% | – |
| Q1 2021 | $40,000 | +11.1% | 12,706 | -7.4% | 0.00% | – |
| Q4 2020 | $36,000 | -10.0% | 13,726 | 0.0% | 0.00% | – |
| Q3 2020 | $40,000 | -14.9% | 13,726 | 0.0% | 0.00% | – |
| Q2 2020 | $47,000 | +9.3% | 13,726 | -36.1% | 0.00% | – |
| Q1 2020 | $43,000 | 0.0% | 21,479 | +99.7% | 0.00% | – |
| Q4 2019 | $43,000 | +34.4% | 10,758 | +6.0% | 0.00% | – |
| Q3 2019 | $32,000 | -23.8% | 10,153 | -5.8% | 0.00% | – |
| Q2 2019 | $42,000 | – | 10,774 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 158,787 | $544,000 | 0.27% |
| Nantahala Capital Management | 990,655 | $3,398,000 | 0.10% |
| FEDERATED HERMES, INC. | 146,097 | $501,000 | 0.00% |
| Paloma Partners Management Co | 24,100 | $83,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 16,984 | $58,000 | 0.00% |
| Berman Capital Advisors, LLC | 1,093 | $3,000 | 0.00% |
| JANE STREET GROUP, LLC | 18,574 | $64,000 | 0.00% |
| NORTHERN TRUST CORP | 30,269 | $103,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 11 | $0 | 0.00% |